1Ryuji K, Azusa F, Takako K, Jun M, Machiko N, Yuri T, et al. Changes in digoxin pharmacokinetics treated with lipopolysacchafide in Wistar rats[J]. Biol Pharm Bull, 2008, 31 (6) : 1221- 1225.
2Dawes M. Drugs in pregnancy. Pharmacokinetics in pregnancy [ J ]. Best Pract Res Clin Obstet Gynaecol, 2001, 15 ( 6 ) : 819- 826.
5Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL. A cardiovascular profile score in the surveillance of fetal hydrops [J]. J Matern Fetal Neonatal Med, 2006, 19(7):407-413.
6Huhta JC ,Quintero R, Ruben A, Sub E, Bader, R. Advance in fetal cardiac intervention [ J ]. Cardiovas Med, 2004, 16 ( 5 ) :487- 493.
7Kondo T, Kitazawa R, Noda-Maeda N, Kitazawa S. Fetal hydrops associated with spontaneous premature closure of ductus arleriosus [J]. Pathol lnt, 2006, 56(9) :554-557.
8Horikoshi T. Fetal hydrops associated with congenital pulmonary myofibroblastic tumor[ J]. J Obstet Gynaecol Res, 2005, 31 (6) : 552-555.
二级参考文献32
1Chaoui R, Heling KS, Taddei F. Doppler echocardiographic analysis of blood flow through the aorta and pulmonary valve in the second half of pregency. Geburtshilfe Frauenheilkd, 1995,55 : 207-212.
2Thomburg KL. Coronary flow regulation in the fetal sheep. Am J Physiol, 1999, 227:1249-1256.
3Tulzer G, Gudmundsson S, Rotondo KM, et al. Acute fetal ductal occlusion in lambs. Am J Obstet Gynecol, 1991, 165:775-781.
4Respondek M, Kammermeier M, Ludomirsky A. The prevalence and clinical significance of fetal tricuspid valve regurgitation with normal heart anatomy. Am J Obstet Gynecol, 1994, 171:1265- 1270.
5Tulzer G, Gudmundsson S, Rotondo KM, et al. Doppler in the evaluation and prognosis of fetuses with tricuspid regurgitation. J Matem Fetal Invest, 1991,1:15-21.
1Patel D,Cuneo B,Viesca R,et al.Digoxin for the treatment of fetal congestive heart failure with sinus rhythm assessed by cardiovascular profile score[J].J Matern Fetal Neonatal Med,2008,21 (7):477-482.
2Krapp M.Baschat AA,Gembruch U,et al.Flecainide in the in trauterine treatment of fetal supraventricular taehycardia[J].Ultrasound Obstet Gynecol,2002,19(2):158-164.
3Simpson JM,Maxwell D,Rosenthal E,et al.Fetal ventricular tachycardia secondary to long QT syndrome treated with maternal intravenous magnesium:Case report and review of the literature[J].Ultrasound Obstet Gynecol,2009,34(4):475-480.
4Martijn AO,Maaike MM,Charles SK,et al.Sotalol in the treatment of fetal dysrhythmias[J].Circulation,2000,101(23):2721-2726.
5Dangel JH,Roszkowski T,Bieganowska K,et al.Adenosine triphosphate for cardioversion of supraventricular tachycardia in two hydropic fetuses[J].Fetal Diagn Ther,2000,15(6):326- 330.
6Mangione R,Guyon F,Vergnaud A,et al.Successful treatment of refractory supraventrieular taehycardia by repeat intravascular injection of amiodarone in a fetus with hydrops[J].Eur J Obstet Gyneeol Reprod Biol,1999,86(1):105-107.
7Sehleieh JM,Bernard Du Haut Cilly F,Laurent MC,et al.Early prenatal management of a fetal ventricular tachycardia treated in utero by amiodarone with long term follow-up[J].Prenat Diagn,2000,20(6):449-452.
8Mevorach D,Elchalal U,Rein AJ.Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies:Detection and treatment of first-degree atrioventricular block[J].Curr Opin Rheumatol,2009,21(5):478-482.
9Dawes M,Chowienczyk PJ.Drugs in pregnancy.Pharmacokinetics in pregnancy[J].Best Pract Res Clin Obstet Gynaecol,2001,15(6):819-826.
10Schmolling J,Renke K,Richter O,et al.Digoxin,flecainide,and amiodarone transfer across the placenta and the effects of an elevated umbilical venous pressure on the transfer rate[J].Ther Drug Monit,2000,22(5):582-588.
